PFE

Pfizer Stock Price

35.91
0.46 (1.3%)
35.91
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Pfizer Inc PFE NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
0.46 1.3% 35.91 04:35:24
Close Price Low Price High Price Open Price Previous Close
35.45
Stock Trades Traded Volume Average Volume 52 Week Range
25 2,663 21,482,480 27.88 - 40.97
Last Trade Time Type Quantity Stock Price Currency
04:35:24 formt 100 $ 35.91 USD

Pfizer Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 199.55B 5.56B 5.54B $ 51.75B $ 8.81B 2.88 15.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
45.16M $ 1.44 4.01% - -

more financials information »

Pfizer News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PFE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week37.0838.28535.3237.2529,248,491-1.17-3.16%
1 Month36.9338.847935.3237.0623,786,543-1.02-2.76%
3 Months38.7639.4833.5637.1722,403,855-2.85-7.35%
6 Months38.4639.5331.6136.4227,104,232-2.55-6.63%
1 Year38.0040.9727.8836.0526,950,419-2.09-5.5%
3 Years35.4346.4727.8838.1322,597,7330.481.35%
5 Years34.2546.4727.8835.8523,464,0301.664.85%

Pfizer Description

Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total firm sales.
Your Recent History
NYSE
PFE
Pfizer
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201029 08:52:32